Radiation therapy of localized diffuse large B-cell lymphoma

Nippon Acta Radiologica

Volumn 63, Issue 3, 2003, Pages 89-92

  Jun, Itami ^a  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

Author keywords

Chemotherapy; Diffuse large B cell lymphoma; Localized; Radiation therapy

Indexed keywords

EID: 25444484708     PISSN: 00480428     EISSN: 13477951     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Miller TP, Dahlberg S, Cassady JR, et al: Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin's lymphoma. N Engl J Med 339: 21-6, 1998
2. Miller TP, Leblanc M, Spier C, et al: CHOP alone compared to CHOP plus radiotherapy for early stage aggressive non-Hodgkin's lymphomas; update of the Southwest Oncology Group (SWOG) randomized trial. Proceedings of ASH 98: 724a-725a, 2001
3. Glick JH, Kim K, Earle J, et al: An ECOG randomized phase III trial of CHOP vs. CHOP+Radiotherapy(XRT)forintermediate grade early stage non-Hodgkin's lymphoma (NHL). Proceedings of ASCO 14: 391, 1995
4. Horning SJ, Glick JH, Kim K, et al: Final report of E1484: CHOP V CHOP+Radiotherapy(RT)for limited stage diffuse aggressive lymphoma. Proceedings of ASH 98: 724a, 2001
5. Fisher RI, Gaynor ER, Dahlberg S, et al: Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. N Engl J Med 328: 1002-1006, 1993
6. Hallahan ED, Farah R, Vokes EE, et al: The patterns of failure in patients with pathological stage I and II diffuse histiocytic lymphoma treated with radiation therapy alone. Int J Radiat Oncol Biol Phys 17: 767-771, 1989
7. Shirato H, Tsujii H, Arimoto T, et al: Early stage head and neck non-Hodgkin's lymphoma: The effect of tumor burden on prognosis. Cancer 58: 2312-2319, 1986
8. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med 329: 987-994, 1993
9. Oguchi M, Ikeda H, Isobe K, et al: Tumor bulk as a prognostic factor for the management of localized aggressive non-Hodgkin's lymphoma; a survey of the Japan Lymphoma Radiation Therapy Group. Int J Radiat Oncol Biol Phys 48: 161-168, 2000
10. Zucca E, Conconi A, Mughal TI, et al: Patterns of outcome and prognostic factors in primary large-cell lymphoma of the testis in a survey by the international extranodal lymphoma study group. J Clin Oncol 21: 20-27, 2003
11. Laskin J, Gascoyne R, Voss N, et al: Primary paranasal sinus lymphoma; natural history and improved outcome with central nervous system chemoprophylaxis. Proceedings of ASCO 20: 298a, 2001
12. Hayabuchi N, Shibamoto Y, Nakamura K, et al: Stage I and II aggressive B-cell lymphomas of the head and neck; radiotherapy alone as a treatment option and the usefulness of the new prognostic index B-ALPS. Int J Radiat Oncol Biol Phys 55: 44-50, 2003
13. Yahalom J, Mauch P: The involved field is back: Issues indelineating the radiation field in Hodgkin's disease. Ann Oncol 13(suppl. 1): 79-83, 2002
14. Kaplan HS: Role of intensive radiotherapy in the management of Hodgkin's disease. Cancer 19: 356-367, 1966
15. Wilder RB, Rodriguez MA, Tucker SL, et al: Radiation therapy after a partial response to CHOP chemotherapy for aggressive lymphomas. Int J Radiat Oncol Biol Phys 50:743-749, 2001
16. Wilder RB, Tucker SL, Ha CS, et al: Dose-response analysis for radiotherapy delivered to patients with intermediate-grade and large-cell immunoblastic lymphomas that have completely responded to CHOP-based induction chemotherapy. Int J Radiat Oncol Biol Phys 49: 17-22, 2001
17. Fuller LM, Krasin MJ, Velasquez WS, et al: Significance of tumor size and radiation dose to local control in stage I-III diffuse large cell lymphoma treated with CHOP-Bleo and radiation. Int J Radiat Oncol Biol Phys 31: 3-11, 1995
18. Kamath SS, Marcus RB Jr, Lynch JW, et al: The impact of radiotherapy dose and other treatment-related and clinical factors on in-field control in stage I and II non-Hodgkin's lymphoma. Int J Radiat Oncol Biol Phys 44: 563-568, 1999
19. Shenkier TN, Voss N, Fairey R, et al: Brief chemotherapy and involved-region irradiation for limited-stage diffuse large-cell lymphoma; an 18-year experience from the British Columbia Cancer Agency. J Clin Oncol 20: 197-204, 2002
20. Tsang RW, Gospodarowicz MK, O'Sullivan B: Staging and management of localized non-Hodgkin's lymphomas: variations among experts in radiation oncology. Int J Radiat Oncol Biol Phys 52: 643-651, 2002
21. Rosenwald A, Wright G, Chan WC, et al: the Lymphoma/Leukemia Molecular Profiling Project ; The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma. N Engl J Med 346: 1937-1947, 2002
22. Coiffier B, Lepage E, Brire J, et al: CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma. N Engl J Med 346: 235-242, 2002